Beyond The Printed Page
-
What Makes A Biopharma Serial Entrepreneur Tick? Part 1
10/28/2019
Rob Wright explores what makes a serial entrepreneur tick (part 1) via Brad Margus, cofounder and CEO of Cerevance. Margus may have started out in the shrimping business, but he went on to found a disease specific 501c3 nonprofit, ultimately leading him to found three different biopharmaceutical companies.
-
The Effect Of Having A Rock Star Cofounder
10/21/2019
John Oyler, cofounder and CEO of BeiGene, a 9-year-old global biopharmaceutical company today valued at more than $8.5 billion, discusses the importance of having a “rock star” scientist cofounder in Xiandong Wang, Ph.D., and his impact on recruiting top talent.
-
Thinking About Becoming An Impact Investor?
10/1/2019
Catherine Clark, a professor at Duke University specializing in impact investing, provides six pieces of wisdom for those considering becoming impact investors.
-
The Lonely Role Of CEO
9/23/2019
Matt Patterson, chairman and CEO of Audentes Therapeutics, provides perspective on what it’s like being the CEO of a startup biopharmaceutical company. Spoiler alert, it isn’t all glitz and glam.
-
What Prepared Matt Patterson To Be CEO Of Audentes Therapeutics
9/16/2019
Matt Patterson, chairman and CEO of Audentes Therapeutics, discusses the experiences that best prepared him for being the CEO of a biopharmaceutical company, including brushes with industry icon Henri Termeer.
-
Pfizer’s Head Of R&D On The Importance Of Being Hyper Focused
8/12/2019
Pfizer’s top scientist, Mikael Dolsten, M.D., Ph.D., talks about being hyper focused during company’s R&D turnaround amongst CEO turnover, company integrations and M&A.
-
How Tony Robbins Became An Investor In Celularity
7/22/2019
Robert Hariri, M.D., Ph.D., discusses how he became friends with life coach Tony Robbins, and why Robbins decided to invest in his company.
-
Support For Women-Led Early-Stage Life Sciences Companies
7/17/2019
A preview of an October 2109 issue article that discusses the results of the 2018 MassNextGen initiative that provides funding and coaching support to early-stage life sciences companies started by females.
-
Robert Hariri’s Accidental Entry Into Filmmaking
7/15/2019
Robert Hariri, M.D., Ph.D., CEO of Celularity Therapeutics, shares how a biopharmaceutical industry CEO has come to know Hollywood celebrities.
-
How LifeBankUSA Became A Life-Changing Investment
7/8/2019
Robert Hariri, M.D., Ph.D., CEO of Celularity, shares a story of an investor’s life being altered dramatically by an investment in one of his companies.